Tazobactam Sodium Salt , ≥98% , 89785-84-2
Synonym(s):
[2S-(2α, 3β, 5α)]-3-Methyl-7-oxo-3(1H,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide;CL-298741;YTR-830H
CAS NO.：89785-84-2
Empirical Formula: C10H12N4NaO5S
Molecular Weight: 323.28
MDL number: MFCD00917472
EINECS: 685-629-4
| Pack Size | Price | Stock | Quantity |
| 100MG | RMB479.20 | In Stock |
|
| 500MG | RMB1039.20 | In Stock |
|
| others | Enquire |
PRODUCT Properties
| Melting point: | 140-147°C |
| Boiling point: | 77℃ |
| Flash point: | >110°(230°F) |
| storage temp. | Keep in dark place,Inert atmosphere,2-8°C |
| solubility | H2O: 50 mg/mL, clear, colorless |
| form | powder |
| color | white |
| optical activity | [α]/D 144±4°, c = 0.1 in H2O |
| Water Solubility | Soluble in water.Soluble in water and methanol. |
| Stability: | Hygroscopic |
Description and Uses
Tazobactam sodium is a new triazolylmethyl beta-lactamase inhibitor launched in combination with the antibiotic piperacillin as tazocilline. Tazobactam sodium is active against penicillinases and wide spectrum of beta-lactamases. The combination product tazobactdpiperacillin is effective against a broad range of both Gram-positive and -negative organisms and is indicated for the treatment of lower respiratory tract, urinary tract, intra-abdominal, biliary and skin and soft tissue infections. It is expected to compete against the combination product augmentin (amoxicillidclavulanate).
A β-lactamase inhibitor and antibacterial agent
Safety
| Symbol(GHS) |  GHS07 |
| Signal word | Warning |
| Hazard statements | H315-H319-H335 |
| Precautionary statements | P271 |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 22-24/25-36-26 |
| WGK Germany | 3 |
| RTECS | XI0191500 |
| HS Code | 2941900000 |
